Naltrexone, methadone, and Suboxone treat opioid use disorder through three different mechanisms. Naltrexone blocks your opioid receptors, reducing cravings without creating dependence. Methadone fully activates those receptors, suppressing withdrawal but carrying higher overdose risk. Suboxone partially activates them, offering the lowest overdose risk while still causing dependence. Each differs in timing, accessibility, and retention rates too. Understanding these distinctions helps you and your provider choose what’s right for your recovery.
How Each Medication Works in Your Body
Although all three medications treat opioid use disorder, they interact with your brain’s opioid receptors in fundamentally different ways. When you compare naltrexone vs methadone vs suboxone, you’re looking at three distinct mechanisms. Naltrexone acts as an opioid blocker, an antagonist that binds opioid receptors without activating them. It prevents opioids from reaching endorphin receptors, eliminating the euphoric and sedative effects, which reduces your cravings over time. It produces no physical dependence. Unlike methadone and suboxone, naltrexone is not classified as an addictive drug. Methadone functions as a long-acting opioid agonist, fully activating mu-opioid receptors to suppress withdrawal and stabilize your state through regular dosing. Suboxone contains buprenorphine, a partial agonist that binds receptors with high affinity but activates them incompletely, creating a ceiling effect. Its naloxone component blocks additional opioids if you misuse it.
When Can You Start Methadone, Suboxone, or Naltrexone?
Timing depends on which medication you’re starting and where you are in withdrawal. You’ll begin methadone or Suboxone during active opioid withdrawal, since starting Suboxone too early can trigger precipitated withdrawal. When initiating methadone for pain, clinicians must account for its drug accumulation over several days due to its lipophilic nature and slow elimination half-life. Naltrexone is different: you’ll need to complete detox first, staying opioid-free for 7 days after short-acting opioids or 10 days after methadone.
Starting During Withdrawal
When you’re starting medication during withdrawal, timing matters differently for each option. Methadone can begin while opioid withdrawal is present, and one emergency protocol required only a COWS score above zero before initiation. It’s the only agonist that doesn’t risk precipitated withdrawal, so you can start it earlier. A common starting range runs from 10 mg to 30 mg once daily, with gradual increases until symptoms and cravings stop. Because methadone is a long-acting opioid with a high potential for physical addiction, it requires careful monitoring throughout treatment.
Suboxone works differently. Because buprenorphine can trigger precipitated withdrawal if you take it too soon after full opioid agonists, you generally start it after withdrawal has begun. Providers use a withdrawal assessment like the COWS scale to time induction, waiting for enough objective withdrawal signs. Starting too early can worsen symptoms rather than relieve them, especially after fentanyl.
Detox Before Naltrexone
Because naltrexone blocks opioid receptors rather than activating them, it demands the longest opioid-free interval of the three medications. You typically need to stop opioids for at least 7 to 10 days before starting oral naltrexone. This requirement highlights a key MAT medications difference: naltrexone is an antagonist, so starting it while opioids remain in your system can precipitate withdrawal. Understanding how they work clarifies this comparison, agonists like methadone and partial agonists like buprenorphine suppress withdrawal, while naltrexone won’t.
Naltrexone doesn’t treat acute withdrawal, so you shouldn’t begin it during active symptoms. Switching from methadone requires complete detoxification first, since methadone is long-acting. Your provider may use a naloxone challenge test or urine opioid testing, often during medically supervised detox, to confirm you’re opioid-free.
Which Has the Highest Overdose Risk?
When you compare overdose profiles, you’ll find each medication carries a distinct risk pattern shaped by how it acts on opioid receptors. Methadone’s status as a full opioid agonist gives it real respiratory depression risk, contributing to higher overdose and mortality rates than buprenorphine/Suboxone. But the comparison isn’t straightforward, because naltrexone actually shows the highest overdose event rate of the three once you account for lost tolerance after treatment stops.
Methadone’s Respiratory Depression Risk
Respiratory depression is methadone’s chief hazard, and it’s the mechanism that drives most opioid overdose deaths. The manufacturer’s boxed warning flags severe respiratory depression as methadone’s most important adverse effect. What makes it dangerous is timing: the respiratory depressant effect can peak later and last longer than the drug’s analgesic effect, so danger may appear hours after dosing rather than immediately. That mismatch raises your risk most during initiation and dose titration, and delayed depression can persist for at least two weeks when methadone’s combined with sedatives like benzodiazepines. Methadone’s long, variable half-life makes it less forgiving than many other opioids. When you add benzodiazepines, the central nervous system effects become additive, increasing the risk of sedation, coma, and death. Close monitoring matters after any change.
Comparing Overdose Profiles
Methadone’s respiratory risks might suggest it carries the highest overdose danger of the three medications, but the comparative data tell a different story. Naltrexone actually shows the highest overdose risk in available comparative studies, especially when you don’t successfully start treatment or stop it early. In one randomized-trial analysis, overdose events by week 24 reached 5.3% for naltrexone, compared with 1.51% for methadone and 1.15% for buprenorphine.
Because naltrexone is an opioid antagonist, your tolerance can drop during treatment, so returning to opioid use produces greater overdose risk. Buprenorphine’s partial-agonist pharmacology keeps its risk lowest, while methadone falls between the two. Importantly, naltrexone hasn’t been shown to reduce mortality and overdose the way methadone and buprenorphine have during active treatment.
Which Medications Cause Physical Dependence?
Because they act on opioid receptors, both methadone and Suboxone can cause physical dependence, while naltrexone doesn’t. Methadone is a full opioid agonist, so your body adapts to it, and stopping abruptly triggers withdrawal. Suboxone contains buprenorphine, a partial agonist that can also produce dependence, though withdrawal risk differs. Naltrexone is an opioid antagonist, it blocks receptors rather than activating them, so the provided sources don’t describe a comparable withdrawal syndrome when you stop it.
Keep these distinctions in mind:
- Methadone: opioid agonist; physical dependence expected with ongoing use
- Suboxone: buprenorphine causes dependence; partial agonist properties lower overdose risk
- Naltrexone: not identified as dependence-forming
- Dependence: defined by withdrawal after stopping, not craving
- Addiction: compulsive use despite harm, distinct from dependence
Where Can You Get Each Medication?
Where you can get each medication depends heavily on how it’s regulated. Naltrexone is prescription-only, available through primary care, specialty care, telehealth, and pharmacies. A licensed provider can prescribe it after evaluating your history. You’ll fill oral tablets at retail pharmacies in generic form, while the monthly extended-release injection requires a practitioner to administer it. Methadone for opioid use disorder works differently. You’ll typically access it through a regulated opioid treatment program (OTP), which SAMHSA identifies as the setting tied to methadone treatment. Clinic-based, supervised dispensing is common, and program enrollment is usually required first. Suboxone falls between the two. You’ll get it from a licensed prescriber in office-based outpatient care, with telehealth prescribing available in some programs and standard pharmacy pickup afterward.
Which One Keeps You in Treatment Longest?
How long you stay in treatment varies by medication, and the evidence points clearly to methadone. In a 30,891-person cohort, discontinuation within 24 months was lower with methadone than buprenorphine/naloxone. Comparative studies consistently rank methadone first for retention, with buprenorphine second and naltrexone last.
- Methadone: 74% retention at 6 months; the least likely treatment cessation among the three medications.
- Buprenorphine: Often 50% or less retention at 6 months, but modestly superior to extended-release naltrexone.
- Naltrexone: Highest discontinuation risk, driven by a difficult induction requiring 7, 14 opioid-free days.
- Easy initiation matters: Methadone and buprenorphine start in withdrawal; naltrexone requires detox first.
- Maintenance matters: Agonist medications keep you engaged longer than antagonist therapy.
A provider can match the right option.
How to Pick the Right Medication for You
Which medication fits you best depends on three factors: your current opioid use status, your withdrawal and detox timing, and the treatment setting you can realistically access. If you’re in active withdrawal, methadone or buprenorphine can reduce symptoms immediately. Naltrexone won’t work yet, you’ll need 7 to 10 opioid-free days first, since it blocks receptors and can trigger withdrawal otherwise.
Setting matters too. Methadone requires a certified opioid treatment program with daily dosing, while buprenorphine can be prescribed in an office and taken at home. Naltrexone can be prescribed by any clinician.
If you want an opioid-free, receptor-blocking approach, naltrexone may suit you. If retention and stabilization are priorities, methadone has the strongest evidence. Make this decision with a provider, alongside counseling and ongoing support.
Call Today and Explore Safer Recovery Options
Medication-assisted recovery can offer powerful support when guided by the right professional team. At The Villa Treatment Center in Woodland Hills, CA, our caring professionals provide trusted Drug Addiction Treatment with understanding and a plan shaped around you. Call +1-818-639-7160 today and take the first step toward lasting recovery.
Frequently Asked Questions
Can You Drink Alcohol While Taking Any of These Medications?
It depends on the medication. With naltrexone, alcohol isn’t strictly forbidden, but it won’t prevent intoxication and can worsen side effects like dizziness, nausea, and liver stress. With methadone or Suboxone, you shouldn’t drink at all, both are opioids, and combining them with alcohol causes dangerous sedation and respiratory depression, raising your overdose risk. Even small amounts are unsafe. Always talk to your provider about alcohol use during treatment.
How Long Do You Stay on MAT Medications?
There’s no fixed end date, your duration depends on your progress, relapse risk, and clinical response. You might stay on MAT for several months, one to two years, or longer-term maintenance when it’s medically appropriate. Methadone is often continued at least 12 months, while buprenorphine/Suboxone is commonly used for at least 6 months. Longer treatment generally produces better outcomes. You and your treatment team reassess periodically, tapering gradually under clinical supervision when appropriate.
Are These Medications Safe During Pregnancy or Breastfeeding?
Yes, but choices differ. Methadone and buprenorphine are the best-studied options during pregnancy, and providers often continue them to maintain stability and reduce relapse risk. Expect newborn monitoring, since opioid exposure can cause neonatal withdrawal. Both are generally compatible with breastfeeding when you’re stable and supervised. Naltrexone has limited pregnancy and breastfeeding data, so it’s less established. You’ll need individualized, specialist guidance to match the right medication to you.
Will These Medications Show up on a Drug Test?
It depends on the test panel ordered. Methadone shows up only when the lab includes a methadone-specific assay, since standard opioid screens often miss it. Suboxone appears as buprenorphine when that’s specifically tested, not as the brand name. Naltrexone isn’t an opioid agonist, so routine screens generally don’t detect it. You won’t get accurate results unless the correct assay is used, and detection varies by sample type, dose, and timing.
Can You Switch Between Methadone, Suboxone, and Naltrexone?
Yes, you can switch between these medications, but each change requires careful clinical management. Moving from methadone to Suboxone means waiting until moderate withdrawal begins, since buprenorphine can precipitate withdrawal otherwise. Switching to naltrexone demands complete detox first, because it’ll trigger withdrawal if opioids remain in your system. Changing from Suboxone to methadone needs monitoring for overdose risk. Your provider will guide timing and tapering to keep you safe throughout.
